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In the last few years Acinetobacter baumannii has emerged worldwide as an important nosocomial pathogen in medical institu-
tions. Here, we present the draft genome sequence of the international clonal lineage 1 (ICL1) A. baumannii strain A144 that was
isolated in a hospital in Buenos Aires City in the year 1997. The strain is susceptible to carbapenems and resistant to trim-
ethoprim and gentamicin.
Received 11 October 2014 Accepted 17 October 2014 Published 26 November 2014
Citation Vilacoba E, Déraspe M, Traglia GM, Roy PH, Ramírez MS, Centrón D. 2014. Draft genome sequence of an international clonal lineage 1 Acinetobacter baumannii strain
from Argentina. Genome Announc. 2(6):01190-14. doi:10.1128/genomeA.01190-14.
Copyright © 2014 Vilacoba et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license.
Address correspondence to Maria Soledad Ramírez, ramirez.mariasoledad@gmail.com.
Acinetobacter baumannii often causes infections in hospitalizedpatients, being one of the major causes of ventilator-
associated pneumonia (1–3).
Extreme levels of resistance, including resistance to carbapen-
ems, tigecycline, and also colistin, has dramatically increased in
the past years (4, 5). In Argentina, A. baumannii has been a wor-
risome problem since the late 1990s, when numerous outbreaks
caused by this microorganism occurred in clinical settings, in par-
ticular in intensive care units (6).
To date, there are only two whole-genome sequences ofA. bau-
mannii strains isolated in Argentina available in GenBank. One of
them corresponds to the naturally competent A. baumannii strain
A118 and the other to a recently extensively drug-resistant A. bau-
mannii indigo-pigmented strain A33405 (7, 8). Here, we an-
nounce the draft genome sequences of A. baumannii 144, which
was isolated in 1997, when carbapenems were introduced into our
clinical settings.
The multilocus sequence typing technique classified A. bau-
mannii 144 as international clonal lineage 1 (ICL1), which is not
the predominant clonal lineage disseminated in Argentina (9).
Whole-genome shotgun sequencing was performed using
Illumina MiSeq- I, using Nextera XT libraries for sample prep-
aration. Reads were assembled with the Ray assembler (http://
denovoassembler.sourceforge.net).
The draft genome sequence of A144 consists of 92 contigs
(length 500 bp), a total sequence of 4,312,914 bp with an N50
contig size of 89,819. The GC% average was 39.2. Using the RAST
server to detect coding regions, we identified 4,151 possible ORFs.
There are six rRNA operons and 69 tRNAs.
A more exhaustive analysis of the drug-resistance determi-
nants harbored by the A144 strain and their contexts and locations
will be included in a future publication. The possibility of analyz-
ing the complete genome sequence of this strain could shed more
light on the knowledge of this important nosocomial pathogen.
These results expand our understanding of the global public
health problem caused by this pathogen and also allow us to com-
pare the genome content of this strain isolated in an Argentinian
hospital to those obtained in the rest of the world.
Nucleotide sequence accessionnumbers.This whole-genome
shotgun project has been deposited at DDBJ/EMBL/GenBank un-
der the accession number JQSF00000000. The version described
in this paper is version JQSF01000000.
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